IN2015KN00516A - - Google Patents
Info
- Publication number
- IN2015KN00516A IN2015KN00516A IN516KON2015A IN2015KN00516A IN 2015KN00516 A IN2015KN00516 A IN 2015KN00516A IN 516KON2015 A IN516KON2015 A IN 516KON2015A IN 2015KN00516 A IN2015KN00516 A IN 2015KN00516A
- Authority
- IN
- India
- Prior art keywords
- ty21a
- vaccines
- recombineered
- recombineering
- compositions
- Prior art date
Links
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 210000003578 bacterial chromosome Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940031348 multivalent vaccine Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0283—Shigella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/25—Shigella (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261701939P | 2012-09-17 | 2012-09-17 | |
| PCT/US2013/059980 WO2014043637A1 (en) | 2012-09-17 | 2013-09-16 | Multifunctional oral vaccine based on chromosome recombineering |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015KN00516A true IN2015KN00516A (enExample) | 2015-07-17 |
Family
ID=50278754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN516KON2015 IN2015KN00516A (enExample) | 2012-09-17 | 2013-09-16 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9750793B2 (enExample) |
| EP (1) | EP2895596A4 (enExample) |
| JP (1) | JP2015533491A (enExample) |
| KR (1) | KR20150058435A (enExample) |
| CN (1) | CN104812890A (enExample) |
| HK (1) | HK1211980A1 (enExample) |
| IL (1) | IL237339B (enExample) |
| IN (1) | IN2015KN00516A (enExample) |
| WO (1) | WO2014043637A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE038861T2 (hu) * | 2013-04-25 | 2018-12-28 | Vaximm Ag | Salmonella-alapú vektorok Wilms-tumor WZ1 gént célzó rák immunterápiához |
| AU2014365900B2 (en) | 2013-12-18 | 2020-04-09 | Vaximm Gmbh | Novel MSLN targeting DNA vaccine for cancer immunotherapy |
| CN105734001B (zh) * | 2014-12-08 | 2020-04-07 | 中国人民解放军军事医学科学院生物工程研究所 | 一种o抗原糖链延长的甲型副伤寒沙门氏菌及其应用 |
| IL256729B2 (en) * | 2015-07-06 | 2023-03-01 | Protein Potential Llc | Live attenuated vaccine for oral administration against shigellosis and typhoid fever |
| GB201519734D0 (en) * | 2015-11-09 | 2015-12-23 | Univ Swansea | Cancer therapy |
| CN106801029B (zh) * | 2017-01-22 | 2020-05-01 | 山东大学 | 一株重组大肠杆菌及其在制备抗志贺氏菌的糖疫苗中的应用 |
| MY190074A (en) * | 2018-01-09 | 2022-03-24 | Aimst Univ | A monovalent vaccine formulation and a method for preparation thereof |
| WO2020163655A1 (en) | 2019-02-06 | 2020-08-13 | Fred Hutchinson Cancer Research Center | Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7541043B2 (en) * | 2002-01-16 | 2009-06-02 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine for protection against Shigella sonnei disease |
| US8071113B2 (en) | 2004-05-24 | 2011-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Live, oral vaccine for protection against Shigella dysenteriae serotype 1 |
-
2013
- 2013-09-16 EP EP13836396.5A patent/EP2895596A4/en not_active Ceased
- 2013-09-16 WO PCT/US2013/059980 patent/WO2014043637A1/en not_active Ceased
- 2013-09-16 HK HK15112845.5A patent/HK1211980A1/xx unknown
- 2013-09-16 KR KR1020157010066A patent/KR20150058435A/ko not_active Ceased
- 2013-09-16 US US14/428,870 patent/US9750793B2/en active Active
- 2013-09-16 CN CN201380059559.5A patent/CN104812890A/zh active Pending
- 2013-09-16 IN IN516KON2015 patent/IN2015KN00516A/en unknown
- 2013-09-16 JP JP2015532125A patent/JP2015533491A/ja active Pending
-
2015
- 2015-02-22 IL IL237339A patent/IL237339B/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL237339A0 (en) | 2015-04-30 |
| KR20150058435A (ko) | 2015-05-28 |
| IL237339B (en) | 2019-06-30 |
| CN104812890A (zh) | 2015-07-29 |
| JP2015533491A (ja) | 2015-11-26 |
| WO2014043637A1 (en) | 2014-03-20 |
| EP2895596A4 (en) | 2016-07-27 |
| EP2895596A1 (en) | 2015-07-22 |
| HK1211980A1 (en) | 2016-06-03 |
| US20150238591A1 (en) | 2015-08-27 |
| US9750793B2 (en) | 2017-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015KN00516A (enExample) | ||
| ZA201603925B (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| EP3364950A4 (en) | VACCINES AGAINST TROPICAL DISEASES | |
| MX352324B (es) | Vacunas multivalentes de nanovehiculos sinteticos. | |
| AU2015296298A8 (en) | Flagellin-based agents and uses including effective vaccination | |
| BR112013010288A2 (pt) | método de produção de uma vacina para proteger um animal de biótipo de microrganismo, vacina para proteger um animal de um biótipo de microrganismo, método para proteger um animal e método para determinar se um animal foi vacinado | |
| EP2825196A4 (en) | ADJUVANZ AND VACCINE COMPOSITIONS | |
| EP2974740A4 (en) | HEPATITIS B VACCINE | |
| IL251120B (en) | Immunogenic/therapeutic glycoside preparations and their uses | |
| ZA201701000B (en) | Attenuated bovine coronavirus and related vaccines | |
| PH12017500304A1 (en) | Vaccine compositions against dengue virus diseases | |
| IL241271A (en) | Al-Thai pertussis vaccine | |
| MA46661A (fr) | Formulations de vaccin glycoconjugué dirigé contre expec | |
| EP3830109A4 (en) | METHODS AND COMPOSITIONS FOR ALPHAVIRUS VACCINATION | |
| GB201801566D0 (en) | Methods and compositions for nanormulsion vaccine formulations | |
| PH12017501795A1 (en) | Pestivirus vaccines for congenital tremors | |
| EP3137111A4 (en) | Compositions and methods for intradermal vaccine delivery | |
| ZA201706867B (en) | Bordetella pertussis immunogenic vaccine compositions | |
| EP3270897A4 (en) | Immunogenic compositions for use in vaccination against bordetella | |
| PL3147351T3 (pl) | Mikroorganizm wykazujący ulepszony poziom wewnątrzkomórkowej energii i sposób wytwarzania l-aminokwasów z jego wykorzystaniem | |
| EP3538197A4 (en) | DEVICES AND METHODS FOR IMPROVING IMMUNOGENICITY TO INTRADERMAL VACCINATION | |
| EA201690378A1 (ru) | Вакцинные композиции против наркотической зависимости | |
| IL256729A (en) | Live attenuated vaccine for oral administration against shigellosis and typhoid fever | |
| MX2018003173A (es) | Vacunas de salmonella choleraesuis-salmonella typhimurium. | |
| TWI563085B (en) | Dendritic cell tumor vaccine and preparation method thereof |